Insights

Rhino Mobility vs. Custom OEM Device: What Healthcare Organisations Should Choose

Rhino Mobility vs. Custom OEM Device: What Healthcare Organisations Should Choose

---

A custom original equipment manufacturer (OEM) device is hardware built to your exact specifications from the ground up. You define the processor, sensors, casing, connectors, and software image. A proven enterprise mobility platform offers pre-engineered devices with configurable options, carrier certifications, and established supply chains. Both paths serve healthcare, but they demand different investments, timelines, and risk profiles.

Healthcare organisations use these devices for clinical workflows such as bedside data entry, remote patient monitoring, medication administration, and specimen tracking. Procurement teams, clinical engineers, and IT security officers all have stakes in the decision. The choice affects how quickly a solution reaches patients, how reliably it operates under clinical pressure, and how long the organisation can sustain it.

This article argues that the right choice depends on where your organisation sits on a spectrum of control versus velocity. Custom OEM devices offer maximum specification control but require significant internal engineering resources and extended timelines. Proven enterprise platforms sacrifice some configurability for faster deployment, established regulatory pathways, and predictable lifecycle management. Most healthcare organisations benefit from understanding this trade-off explicitly before committing capital.

Custom OEM Devices Offer Maximum Control at Maximum Cost

A custom OEM engagement starts with your requirements document. You select the system-on-chip, battery chemistry, display treatment, ingress protection rating, and every peripheral interface. The manufacturer builds tooling, validates the design, and produces units exclusively for your program.

This path suits organisations with unique clinical constraints. A device that must interface with proprietary diagnostic hardware through a non-standard connector, or operate in a sterile field with specific chemical resistance, may justify custom engineering. The resulting device carries your brand and no other.

The challenges are substantial. Design validation for healthcare can take 18 to 36 months. You assume responsibility for software maintenance, security patch integration, and regulatory documentation. If the device handles protected health information (PHI) or connects to diagnostic equipment, your team navigates FDA considerations, IEC 60601 electrical safety testing, and ongoing compliance monitoring. The total cost of ownership (TCO) extends far beyond unit price into engineering salaries, regulatory consultants, and long-term software support.

Proven Platforms Reduce Time-to-Clinical-Value

Rhino Mobility's second-generation platform builds on over one million deployed devices across enterprise and government, including healthcare deployments such as Endotronix's remote cardiac monitoring program. The platform includes handheld scanners, tablets, and connectivity modules with AT&T 5G RedCap certification, indicating carrier-validated network performance.

For healthcare IT, this translates to several practical advantages. Hardware arrives pre-certified for electromagnetic compatibility and radio emissions. Android Enterprise integration provides standardised mobile device management (MDM) enrolment, kiosk mode configuration, and security policy enforcement. The supply chain exists; you are not waiting for chip allocation or factory capacity.

Endotronix replaced unreliable tablets with Rhino Mobility devices and reduced system crashes while restoring provider confidence in remote cardiac monitoring. Their deployment did not require custom hardware design. Instead, they leveraged purpose-built enterprise devices with guaranteed three-year availability and software support longevity, allowing their clinical engineering team to focus on patient-facing application development rather than hardware validation.

Where the Two Paths Diverge in Practice

Evaluation Dimension Custom OEM Device Proven Enterprise Platform
Time to first clinical use 18–36 months typical 3–9 months typical
Specification control Complete Configurable within platform options
Regulatory burden Borne primarily by your organisation Shared with platform vendor's existing certifications
Software maintenance Your engineering team or contracted vendor Vendor-provided with defined lifecycle
Supply chain risk Concentrated on single program Distributed across vendor's customer base
Unit economics at scale Potentially lower per-unit at very high volumes Predictable, with volume tiers
Branding Full white-label capability Limited to co-branding or standard finish

Three Questions to Guide Your Decision

Does your clinical workflow require hardware that does not exist?

If your device must incorporate a novel biosensor, custom optical path, or proprietary physical interface, custom OEM may be unavoidable. If your need centres on reliable data capture, barcode scanning, secure connectivity, and clinical software access, a proven platform likely suffices.

What is your internal engineering capacity for ongoing device stewardship?

Custom hardware demands ongoing attention. Security patches, Android version migrations, carrier recertifications, and component end-of-life transitions require dedicated resources. Healthcare IT teams already stretched by electronic health record (EHR) integration and cybersecurity operations may lack bandwidth for hardware lifecycle management.

How predictable must your total cost be over five years?

Custom programs often encounter cost growth during design validation, regulatory submission, or production ramp. Enterprise platforms publish pricing structures and lifecycle commitments. For budget-constrained health systems or startups seeking clinical evidence before scale investment, this predictability matters.

When a Hybrid Approach Fits

Some organisations begin with a proven platform for pilot programs and limited clinical trials, then transition to custom hardware only after validating market demand and exact specifications. This reduces early risk while preserving customisation for mature, high-volume deployments. The platform serves as a clinical and commercial bridge.

Rhino Mobility's platform supports this model. Devices such as the T85 and T105 tablets offer configurable elements, accessories, software images, and management policies, without requiring full custom engineering. Organisations gain clinical feedback quickly, then decide whether unique hardware requirements justify a later custom program.

Frequently Asked Questions

How long does a typical custom OEM healthcare device take from concept to clinical deployment?

Most programs require 24 to 36 months, with regulatory validation and software stabilization consuming the largest portions. Enterprise platforms typically deploy in under 12 months, with some configurations ready in 90 days.

Can a proven enterprise platform meet FDA requirements for connected medical devices?

Platform hardware can support FDA-cleared software as a medical device (SaMD) or serve as a component in a larger system. The platform vendor's existing quality processes and documentation often accelerate your submission. However, you still navigate the software and clinical portions of your specific indication.

What happens to device support if the platform vendor changes ownership or strategy?

Evaluate the vendor's track record, contractual lifecycle commitments, and financial stability. Rhino Mobility builds on a platform with over one million deployed devices and multi-year carrier certifications, indicating sustained investment. Request written availability and security-update guarantees during procurement.

Is barcode scanning quality materially different between custom and platform devices?

Not necessarily. Purpose-built enterprise scanners, such as the RHINO T5se with Honeywell scan engine, match or exceed many custom implementations. The key factor is whether your workflow demands a specific scan symbology, range, or ergonomic integration that platform options cannot address.

How do security update commitments compare between the two approaches?

Custom OEM security updates depend entirely on your engineering contract or internal capacity. Enterprise platforms typically publish defined update timelines. Rhino Mobility devices include guaranteed multi-year software support, reducing vulnerability exposure without requiring your team to integrate patches manually.

Match the Path to Your Organisation's Maturity

The decision between custom OEM and a proven enterprise platform is not about which technology is superior. It is about which investment profile aligns with your clinical timeline, engineering resources, and risk tolerance. Custom devices reward organisations with unique hardware requirements and the capacity to manage long development cycles. Proven platforms reward those prioritising speed, regulatory de-risking, and operational focus.

For healthcare organisations evaluating clinical mobility, Rhino Mobility offers a purpose-built platform with healthcare-relevant form factors, carrier certifications, and lifecycle commitments. Whether your need is immediate deployment or a foundation for future customisation, the platform provides a defined starting point without the open-ended obligations of full custom engineering.

This content may have been generated in whole or in part using artificial intelligence tools. While reviewed for accuracy prior to publication, Rhino Mobility makes no warranties regarding the completeness or reliability of AI-assisted content and disclaims liability for errors or omissions. This content is for general informational purposes.